Profitelligence Profitelligence · Filing Ledger Open PURR research →

Form 8-K/A · Current Report · Filed 2026-02-18

Sonnet BioTherapeutics Holdings, Inc. Completed Merger with Hyperliquid Strategies Inc.

Sonnet BioTherapeutics Holdings, Inc. completed its merger with Hyperliquid Strategies Inc. on December 2, 2025, becoming a wholly-owned subsidiary. The transaction resulted in the issuance of 239,921,355 shares of Hyperliquid common stock to Sonnet's former shareholders and the delisting of Sonnet's stock from Nasdaq. Financial statements and pro forma information were provided to reflect the company's position post-merger.

Filer
Hyperliquid Strategies Inc. PURR · NASDAQ
Filed
Accession
0001193125-26-055449
CIK
0002078856
Signal
High impactFinancial Services

Items reported

Item events

Reported Item

M&A Transaction Financial Instrument Agreement Share Repurchase Program Announced

Market reaction

Close before filing

$4.22

Next session

-4.7%

Since filing

+188.6%

Latest close

$12.18

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from PURR reporting the same item, with the next session's move:

Hyperliquid Strategies Reports Q2 2025 Financial Results and Treasury Strategy Progress-8.0%

Exhibits (2)

About Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is a digital asset treasury company specializing in the accumulation and management of HYPE, the native token of the Hyperliquid blockchain. This high-performance Layer-1 blockchain is designed to host comprehensive financial activities, including decentralized perpetual futures and spot trading on its leading exchange, which processes billions in daily volume and serves hundreds of thousands of global traders. Incorporated in 2025 and headquartered in New York, New York, the company resulted from a business combination with Sonnet BioTherapeutics Holdings, Inc., allowing Sonnet to operate as a wholly-owned subsidiary while shifting primary focus to digital assets. Hyperliquid Strategies Inc. holds substantial reserves of HYPE tokens, valued at approximately 583 million, and employs strategies like staking, yield optimization, and ecosystem engagement to maximize shareholder value. Led by CEO David Schamis and Chairman Bob Diamond, it provides U.S. and institutional investors with capital-efficient exposure to one of the fastest-growing revenue-generating blockchains in the digital asset space, bridging traditional equity markets with innovative blockchain finance.

Exchange NASDAQ Industry Capital Markets Company website ↗

Never miss another PURR filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts